Top Markets
Coin of the day
ContextVision AB (publ) ContextVision AB (publ)

ContextVision AB (publ)

0L8Z
株式のランク #27950
ContextVision AB (publ), a Swedish medical technology company established in... ContextVision AB (publ), a Swedish medical technology company established in 1983 and headquartered in Stockholm, develops sophisticated image analysis and artificial intelligence software. These solutions are supplied to original equipment manufacturers (OEMs) across Asia, Europe, and the United States. The firm specializes in enhancing image quality for various medical imaging technologies, including 2D/3D/4D ultrasound, radiography, magnetic resonance imaging (MRI), and mammography. Key products in their lineup include Rivent, which delivers exceptional image clarity for diverse ultrasound applications such as women's health, general imaging, cardiovascular, and point-of-care. They also offer VolarView for improved visuals in handheld ultrasound devices, and GOPiCE, providing real-time volumetric image enhancement. Furthermore, ContextVision provides Altumira/Altumira Plus, a dedicated platform for digital radiography, alongside an Orthopedic Package for skeletal imaging. Their offerings extend to GOPView MRI2Plus for advanced MRI image refinement and INIFY Prostate Screening, a tool for the digital analysis of prostate biopsies.
株価
$0.39098275
最終同期: 2026-02-11
時価総額
$29.58M
変化(1日)
0.01%
変化(1年)
-12.48%
SE
取引 ContextVision AB (publ) (0L8Z)

カテゴリー

ContextVision AB (publ)(0L8Z)の収益
Aug 2026 時点の収益 TTM: 0
ContextVision AB (publ) の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
ContextVision AB (publ) の収益履歴(2026 ~ 2026)
各年末の収益
収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益
企業 収益 収益の差
- -
DE
- -
CA
$42.83B -
US
$55.23B -
US
$14.73B -
US